Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.

Gram-positive bacteria have become the predominant infecting organisms in granulocytopenic cancer patients. Empiric antibiotic regimens used in febrile neutropenic patients often include an extended-spectrum cephalosporin, but the response to therapy in gram-positive coccal bacteremia has been unsat...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Cometta, A, Zinner, S, de Bock, R, Calandra, T, Gaya, H, Klastersky, J, Langenaeken, J, Paesmans, M, Viscoli, C, Glauser, M P
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162558/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7726513/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.2.445
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!